SCHEMBL7063237

SCHEMBL7063237

O=C(O)COc1cc(Cl)ccc1C(=O)NCc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 9/20 0.72
AKR1B10 O60218 1/20 0.61
PPARA Q07869 2/20 0.49
PPARD Q03181 1/20 0.49
RORC P51449 1/20 0.48
PTGER4 P35408 1/20 0.48
EPHX2 P34913 3/20 0.48
NR1H4 Q96RI1 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HTR2C P28335 1/20 0.47
AKR1C3 P42330 1/20 0.47
PDE2A O00408 1/20 0.46
PPARG P37231 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064934 0.89 AKR1B1 (0.86) AKR1B1AKR1B10PTGER4ALDH1A1GAA
SCHEMBL7063273 0.85 AKR1B1 (0.77) AKR1B1AKR1B10PPARAPPARDALDH1A1
SCHEMBL5470955 0.85 AKR1B1 (0.80) AKR1B1AKR1B10ALDH1A1GAAHPGD
SCHEMBL7059964 0.84 AKR1B1 (1.00) AKR1B1AKR1B10PTGER4ALDH1A1GAA
SCHEMBL7059962 0.83 AKR1B1 (0.67) AKR1B1AKR1B10HPGDAKR1C3
SCHEMBL14447219 0.82 AKR1B1 (0.71) AKR1B1AKR1B10PTGER4L3MBTL1AKR1C3
SCHEMBL7065043 0.82 AKR1B1 (0.75) AKR1B1AKR1B10ALDH1A1GAAHPGD
SCHEMBL17241841 0.82 HTR2C (0.54) AKR1B1PPARAPPARDPTGER4EPHX2
SCHEMBL7063092 0.81 AKR1B1 (0.67) AKR1B1AKR1B10GAAHPGD
SCHEMBL7066268 0.80 AKR1B1 (0.62) AKR1B1AKR1B10PPARAPPARDPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US claimed
JP-2003503381-A 2003-01-28 JP claimed
US-6420426-B1 USED TO TREAT COMPLICATIONS FROM DIABETES MELLITUS THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2002-07-16 US claimed
EP-1198451-A2 SUBSTITUTED PHENOXYACETIC ACIDS The Institutes for Pharmaceutical Discovery, LLC (US) 2002-04-24 EP claimed
WO-2001000566-A2 SUBSTITUTED PHENOXYACETIC ACIDS THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2001-01-04 WO claimed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161631-A1 Substituted Phenoxyacetic Acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885PPARA 20/4885
US-20030036558-A1 Substituted phenoxyacetic acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885PPARA 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.